Novo Nordisk is a focused healthcare company. With the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems, Novo Nordisk is a world leader in diabetes care. In addition, Novo Nordisk has a leading position in areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.
Novo Nordisk Pharma (Taiwan) Ltd.
Address：10F., No. 207, Sec. 2, Dunhua S. Rd., Da’an Dist., Taipei City 106, Taiwan
Official Website： http://www.novonordisk.com.tw/